m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00002
|
[1] | |||
: modification sites
Direct
Enhancement
m6A modification
CDKN1A
CDKN1A
METTL14
Methylation
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 14 (METTL14) | WRITER | |||
| m6A Target | Cyclin-dependent kinase inhibitor 1 (CDKN1A) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> 5-methylcytidine (m5C) | ||||
| Epigenetic Regulator | RNA cytosine C(5)-methyltransferase NSUN2 (NSUN2) | WRITER | View Details | ||
| Regulated Target | Cyclin-dependent kinase inhibitor 1 (CDKN1A) | View Details | |||
| Crosstalk Relationship | m5C → m6A | Enhancement | |||
| Crosstalk Mechanism | RNA modification directly impacts m6A modification through targeting the shared RNA | ||||
| Crosstalk Summary | NSUN2-mediated m5C and METTL3/METTL14-mediated m6A methylation synergistically enhance Cyclin-dependent kinase inhibitor 1 (CDKN1A) expression at the translational level, leading to elevated expression of p21 in oxidative stress-induced cellular senescence. | ||||
| Cell Process | Cellular senescence | ||||
In-vitro Model |
HCT 116 TP53(-/-) | Colon carcinoma | Homo sapiens | CVCL_HD97 | |
| HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | ||
: modification sites
: m6A sites